Concepedia

Publication | Open Access

First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold

200

Citations

40

References

2012

Year

Abstract

URL: http://www.clinicaltrials.gov. Unique identifier: NCT00856856.

References

YearCitations

Page 1